OTCMKTS:SHJBF Shanghai Junshi Biosciences (SHJBF) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free SHJBF Stock Alerts C$1.86 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's RangeC$1.86▼C$1.8650-Day RangeC$1.86▼C$2.0652-Week RangeC$0.95▼C$2.06VolumeN/AAverage Volume100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Shanghai Junshi Biosciences alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Shanghai Junshi Biosciences Stock (OTCMKTS:SHJBF)Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.Read More SHJBF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SHJBF Stock News HeadlinesApril 26, 2024 | wsj.comShanghai Junshi Biosciences Co. Ltd.April 24, 2024 | finance.yahoo.comJunshi Biosciences Announces NDA Acceptance in Hong Kong for ToripalimabApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.February 2, 2024 | finance.yahoo.comJunshi Biosciences Announces Toripalimab’s NDA Accepted by the Singapore Health Sciences AuthorityJanuary 18, 2024 | finance.yahoo.comJunshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung CancerJanuary 11, 2024 | investing.comShanghai Junshi Biosciences Co Ltd (1877)January 10, 2024 | finance.yahoo.comJunshi Biosciences Announces Publication of Results from TORCHLIGHT, a Randomized Phase 3 Trial of Toripalimab for the Treatment of Metastatic or Recurrent Triple-negative Breast Cancer in Nature MedicineJanuary 6, 2024 | forbes.comShanghai LujianziApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.January 5, 2024 | travel.usnews.comWhat to Eat in ShanghaiJanuary 5, 2024 | msn.comInovio stock surges to seven-month highJanuary 2, 2024 | finance.yahoo.comJunshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC PatientsDecember 12, 2023 | bbc.comHow long will Shanghai's lockdown last?December 3, 2023 | seekingalpha.comWeek In Review: Tang Capital Offers $465M For LianBio Plus 80% Of Any Licenses/DivestmentsDecember 1, 2023 | finance.yahoo.comJunshi Biosciences Announces New Chemical Entity Application for Toripalimab Accepted by Australia’s TGANovember 28, 2023 | msn.comCoherus cancer drug undercuts Merck's KeytrudaNovember 22, 2023 | finance.yahoo.comJunshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19October 31, 2023 | msn.comCoherus, Shanghai Junshi Shares Gain After U.S. Approval For Nasopharyngeal Cancer DrugOctober 30, 2023 | msn.comJunshi-Coherus' Loqtorzi cancer drug wins FDA approvalOctober 27, 2023 | finance.yahoo.comJunshi Biosciences Presents 11 Clinical Trials of Toripalimab at the ESMO Congress 2023July 19, 2023 | finance.yahoo.comJunshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab as the First-line Treatment of Extensive-stage Small Cell Lung CancerJuly 15, 2023 | morningstar.comShanghai Junshi Biosciences Co Ltd Class HJuly 11, 2023 | finance.yahoo.comJunshi Biosciences Announces Acceptance of the Supplemental New Drug Application for ToripalimabJune 19, 2023 | wsj.comShanghai OPM Biosciences Co. Ltd. AMay 23, 2023 | seekingalpha.comJunshi's toripalimab gets Chinese regulator review for expanded use in breast cancerMay 23, 2023 | finance.yahoo.comJunshi Biosciences Announces Acceptance of the Supplemental NDA for Toripalimab in Combination with Chemotherapy for Advanced Triple-negative Breast CancerMay 18, 2023 | investing.comShanghai OPM Biosciences Co Ltd (688293)See More Headlines Receive SHJBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shanghai Junshi Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:SHJBF CUSIPN/A CIKN/A Webwww.junshipharma.com Phone86 21 6105 8800FaxN/AEmployees2,568Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Jun Xiong (Age 50)Executive Chairman Mr. Cong Li (Age 60)Co-CEO & Executive Director Dr. Jianjun Zou (Age 52)GM, CEO & Executive Director Mr. Baohong Xu (Age 45)Financial Director Mr. Zhuobing Zhang (Age 56)Deputy GM & Executive Director Dr. Sheng Yao Ph.D. (Age 48)Senior VP & Executive Director Dr. Gang Wang (Age 67)Executive Director, Chief Quality Officer & Senior VP of Industry Affairs Ms. Yingge Chen (Age 32)Joint Company Secretary Ms. Lu Yuan (Age 42)Assistant to GM & Chief of Internal Audit Department Mr. Qian WeiChief Commercial OfficerMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors SHJBF Stock Analysis - Frequently Asked Questions How have SHJBF shares performed in 2024? Shanghai Junshi Biosciences' stock was trading at C$2.15 at the beginning of 2024. Since then, SHJBF stock has decreased by 13.5% and is now trading at C$1.86. View the best growth stocks for 2024 here. Are investors shorting Shanghai Junshi Biosciences? Shanghai Junshi Biosciences saw a decline in short interest in March. As of March 15th, there was short interest totaling 636,100 shares, a decline of 36.7% from the February 29th total of 1,005,300 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days. View Shanghai Junshi Biosciences' Short Interest. How do I buy shares of Shanghai Junshi Biosciences? Shares of SHJBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SHJBF) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shanghai Junshi Biosciences Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
